CA
NZ
UK
AU
IND
US
RxSight announced that Aziz Mottiwala will assume the roles of President and Chief Executive Officer, bringing a compensation structure designed to align his interests with the company’s turnaround objectives. The appointment follows a series of leadership transitions that have reshaped the company’s executive team …
SAB Biotherapeutics secured a research grant with Breakthrough T1D to evaluate its experimental diabetes therapy SAB-142, a development that lifted shares despite recent financial challenges. While the company faced headwinds in its latest quarterly performance, the grant and upcoming clinical milestones have shifted investor …
Tango Therapeutics is positioning itself as a key contender in the competitive KRAS inhibitor space, with analysts emphasizing the potential of its vopimetostat and daraxonrasib combination. Shares of the biotech firm climbed 2.7% to $30.46 in recent trading, reflecting growing investor interest despite recent …
Price $5.73 (+0.5% today) · Mkt cap $1.9B · $200M gross proceeds from offering · Next catalyst: June 24 public offering pricing Taysha Gene Therapies (NASDAQ: TSHA) announced a public offering that will bring in about $200 million. The deal consists of 32.5 million …
Vaxcyte has added John Markels to its board of directors, filling the seat left by retiring member Heath Lukatch after more than eight years of service. The move, effective immediately, brings additional governance oversight to the vaccine developer as it advances its clinical pipeline. …
Regen BioPharma has resolved a claim by agreeing to issue shares to creditors at a 65% payout rate, a move that could dilute existing shareholders. The settlement allows Trillium Partners to sell the shares and retain 65% of the proceeds until the full claim …
NeOnc Technologies obtained detailed FDA commentary on its NEO212 manufacturing program, enabling the firm to forego a previously scheduled meeting on July 9. The guidance focuses on the chemistry, manufacturing and controls needed to shift the drug from a capsule to a tablet format …
NextPlat Corp has entered into a cash purchase agreement to acquire Scott’s Pharmacy, a community pharmacy in Florida that contributes approximately $5.6 million in annual revenue. The transaction, disclosed in a regulatory filing, expands the company’s retail footprint into northwest Florida, a region described …
Pfizer Inc. (NYSE: PFE) received U.S. regulatory clearance for a new bladder cancer treatment, driving its stock higher as investors anticipate additional revenue opportunities. The FDA approved PADCEV in combination with Keytruda for adults with muscle-invasive bladder cancer (MIBC), broadening the therapy’s application beyond …
Q32 Bio has obtained fresh capital through a public offering where the shares were priced at $18.25, a modest discount to the prior closing level. The underwriting syndicate retained a 30‑day option to buy up to 1,643,835 further shares, providing flexibility for additional funding …
Please wait processing your request...